Triveen — Class III drug recall D-1544-2014
Terminated recall by Trigen Laboratories, Inc., reported 2014-08-27, distributed nationwide. Labeling: Not Elsewhere Classified: Label indicates that the product contains Vitamin B12 (12 micrograms) on t
| Recall number | D-1544-2014 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Trigen Laboratories, Inc., Tampa, FL, United States |
| Recall initiated | 2014-04-17 |
| Classified | 2014-08-19 |
| Reported by FDA | 2014-08-27 |
| Terminated | 2017-07-26 |
| Distributed | Nationwide (US) |
| Quantity | 142,732 bottles |
| Reason classes | labeling |
| UPC / GTIN / UDI-DI | 00313811558302 |
| NDC | 13811-0558-30 |
| Lot numbers | 03/15, 06/15, 08/15, 09/15, 10/15, 505024006, 505024007, 505024008, 505024009, 505024010, 505024011, 505024012 |
Product
Triveen - PRx RNF Capsules, 30-count bottles, Rx only; Manufactured for: Trigen Laboratories, Inc., Sayreville, NJ 08872, NDC 13811-558-30, UPC 3 13811 55830 2.
Reason for recall
Labeling: Not Elsewhere Classified: Label indicates that the product contains Vitamin B12 (12 micrograms) on the Supplement Facts panel, however, the formulation of this product does not contain Vitamin B12.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1544-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.